These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32776229)

  • 41. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
    Sun L; Liu L; Yang J; Li H; Zhang C
    J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
    Kim JH; Ahn JH; Lee M
    Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
    Lambrou GI; Adamaki M; Hatziagapiou K; Vlahopoulos S
    Curr Drug Res Rev; 2020; 12(2):131-149. PubMed ID: 32077838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
    Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
    Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
    Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
    Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
    Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
    Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
    Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells.
    Yang X; He G; Gong Y; Zheng B; Shi F; Shi R; Yang X
    Eur J Haematol; 2014 Feb; 92(2):111-20. PubMed ID: 24112092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
    Wang XW; Xu YH
    Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
    Fan X; Huang X; Li Z; Ma X
    J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV16
    Pulati N; Zhang Z; Gulimilamu A; Qi X; Yang J
    J Gene Med; 2019 Nov; 21(11):e3126. PubMed ID: 31498525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
    Kotani A; Ha D; Schotte D; den Boer ML; Armstrong SA; Lodish HF
    Cell Cycle; 2010 Mar; 9(6):1037-42. PubMed ID: 20237425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
    Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-141-3p inhibits retinal neovascularization and retinal ganglion cell apoptosis in glaucoma mice through the inactivation of Docking protein 5-dependent mitogen-activated protein kinase signaling pathway.
    Zhang LQ; Cui H; Yu YB; Shi HQ; Zhou Y; Liu MJ
    J Cell Physiol; 2019 Jun; 234(6):8873-8887. PubMed ID: 30515784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of Prednisolone on miR 15a and miR16-1 Expression Levels and Apoptosis in Acute Lymphoblastic Leukemia Cell Line: CCRF-CEM.
    Azimi A; Hagh MF; Yousefi B; Rahnama MA; Khorrami A; Heydarabad MZ; Najafpour M; Hallajzadeh J; Ghahremani A
    Drug Res (Stuttg); 2016 Aug; 66(8):432-5. PubMed ID: 27281445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time--and Concentration--Dependent Effects of Resveratrol on miR 15a and miR16-1 Expression and Apoptosis in the CCRF-CEM Acute Lymphoblastic Leukemia Cell Line.
    Azimi A; Hagh MF; Talebi M; Yousefi B; Hossein pour feizi AA; Baradaran B; Movassaghpour AA; Shamsasenjan K; Khanzedeh T; Ghaderi AH; Heydarabad MZ
    Asian Pac J Cancer Prev; 2015; 16(15):6463-8. PubMed ID: 26434860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.